NewEdge Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

NewEdge Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,171	Closed	-$65.5K	–	4349
2022 Q4	$65.5K	Buy	+2,171	New	+$69.9K	﹤0.01%	1613
2022 Q2	–	Sell	-24,756	Closed	-$643K	–	1638
2022 Q1	$643K	Buy	+24,756	New	+$589K	0.01%	776

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

NewEdge Advisors's VIVO Position: Q1 2023 in Review

NewEdge Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,171 shares — an estimated $65.5K sold.

NewEdge Advisors first reported a position in VIVO in Q1 2022 and held it in 2 quarters. The position peaked at $643K in Q1 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

NewEdge Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 2,171 Meridian Bioscience Inc shares in Q1 2023, an estimated $65.5K.
NewEdge Advisors first reported a position in Meridian Bioscience Inc in Q1 2022 and held it in 2 quarters.
NewEdge Advisors's Meridian Bioscience Inc position peaked at $643K in Q1 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.